Royal Bank of Canada »

4d Molecular Therapeutics In shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $268k 13k 20.23
2023-09-30 $0 6.5k 0.00
2023-06-30 $81k 3.2k 25.00
2022-12-31 $64k 3.5k 18.52
2022-09-30 $0 435 0.00
2021-06-30 $0 675 0.00
2021-03-31 $31k 713 43.48